Literature DB >> 1452081

Intrahepatic expression of pre-S1 and pre-S2 antigens in chronic hepatitis B virus infection in relation to hepatitis B virus replication and hepatitis delta virus superinfection.

C M Chu1, Y F Liaw.   

Abstract

Hepatocyte expression of pre-S1 and pre-S2 in relation to hepatitis B virus replication (hepatitis B virus-DNA in serum and HBcAg in the liver), histological activity and hepatitis delta virus superinfection was studied by indirect immunofluorescence on frozen sections of liver specimens from 68 patients with chronic hepatitis B virus infection. All 44 patients with chronic type B hepatitis had pre-S1 and pre-S2 display in the liver. The distribution of pre-S1 in the liver was membranous in one, mixed membranous and cytoplasmic in 12, and cytoplasmic in 31. The distribution of pre-S2 was membranous in one, mixed membranous and cytoplasmic in 26, and cytoplasmic in 17. Membranous expression of pre-S1 was significantly more prevalent in patients with active hepatitis B virus replication than in those without (13/28 v 0/16, p < 0.001), regardless of the histological activity, as was membranous expression of pre-S2 (27/28 v 0/16, p < 0.001). In contrast, a significantly higher extent of cytoplasmic expression of pre-S1 and pre-S2 was noted in patients without active hepatitis B virus replication than in those with. Of 24 patients with chronic type D hepatitis virus, eight had active hepatitis B virus replication, and the other 16 did not. The distribution and quantitative expression of pre-S1 and pre-S2 in the liver in these patients also correlated significantly with the status of hepatitis B virus replication and, moreover, showed little or no difference from those without hepatitis delta virus infection. In conclusion, all patients with chronic type B hepatitis had synthesis and display of pre-S1 and pre-S2 in the liver. The distribution and quantitative expression of pre-S1 and pre-S2, however, were closely related to the status of hepatitis B virus replication, but not to the histological activity. Hepatocyte expression of pre-S1 and pre-S2 in chronic type D hepatitis also correlated significantly with status of hepatitis B virus replication, and was not modulated by concurrent hepatitis delta virus infection.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452081      PMCID: PMC1379543          DOI: 10.1136/gut.33.11.1544

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  33 in total

1.  Hepatic expression patterns of the large and middle hepatitis B virus surface proteins in viremic and nonviremic chronic hepatitis B.

Authors:  H P Dienes; W H Gerlich; M Wörsdörfer; G Gerken; L Bianchi; G Hess; K H Meyer zum Büschenfelde
Journal:  Gastroenterology       Date:  1990-04       Impact factor: 22.682

2.  Demonstration of pre-S polypeptides of hepatitis B virus in infected livers.

Authors:  S N Thung; M A Gerber; E J Kasambalides; B K Gilja; W Keh; W H Gerlich
Journal:  Hepatology       Date:  1986 Nov-Dec       Impact factor: 17.425

3.  Asymmetric budding of viruses in epithelial monlayers: a model system for study of epithelial polarity.

Authors:  E Rodriguez Boulan; D D Sabatini
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Large surface proteins of hepatitis B virus containing the pre-s sequence.

Authors:  K H Heermann; U Goldmann; W Schwartz; T Seyffarth; H Baumgarten; W H Gerlich
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

5.  Transmission of the hepatitis B virus-associated delta antigen to chimpanzees.

Authors:  M Rizzetto; M G Canese; J L Gerin; W T London; D L Sly; R H Purcell
Journal:  J Infect Dis       Date:  1980-05       Impact factor: 5.226

6.  Signals regulating hepatitis B surface antigen transcription.

Authors:  R Cattaneo; H Will; N Hernandez; H Schaller
Journal:  Nature       Date:  1983 Sep 22-28       Impact factor: 49.962

7.  Pre-S1 antigens and antibodies early in the course of acute hepatitis B virus infection.

Authors:  M Q Klinkert; L Theilmann; E Pfaff; H Schaller
Journal:  J Virol       Date:  1986-05       Impact factor: 5.103

8.  Detection of pre-S1 proteins in serum and liver of HBsAg-positive patients: a new marker for hepatitis B virus infection.

Authors:  L Theilmann; M Q Klinkert; K Gmelin; J Salfeld; H Schaller; E Pfaff
Journal:  Hepatology       Date:  1986 Mar-Apr       Impact factor: 17.425

9.  Serum titers of pre-S(2) antigen in patients with acute and chronic type B hepatitis: relation to serum aminotransferase activity and other hepatitis B virus markers.

Authors:  K Kurai; S Iino; K Koike; K Mitamura; Y Endo; H Oka
Journal:  Hepatology       Date:  1989-02       Impact factor: 17.425

10.  Changes of serum hepatitis B virus DNA in two types of clinical events preceding spontaneous hepatitis B e antigen seroconversion in chronic type B hepatitis.

Authors:  Y F Liaw; C C Pao; C M Chu; I S Sheen; M J Huang
Journal:  Hepatology       Date:  1987 Jan-Feb       Impact factor: 17.425

View more
  3 in total

Review 1.  Significance of the interferon (IFN) in the therapy.

Authors:  Sabina Mahmutović; Edina Beslagić
Journal:  Bosn J Basic Med Sci       Date:  2004-10       Impact factor: 3.363

2.  Low-level viremia and intracellular expression of hepatitis B surface antigen (HBsAg) in HBsAg carriers with concurrent hepatitis C virus infection.

Authors:  C M Chu; C T Yeh; Y F Liaw
Journal:  J Clin Microbiol       Date:  1998-07       Impact factor: 5.948

3.  Coexpression of intercellular adhesion molecule-1 and class I major histocompatibility complex antigens on hepatocyte membrane in chronic viral hepatitis.

Authors:  C M Chu; Y F Liaw
Journal:  J Clin Pathol       Date:  1993-11       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.